Table 2

CV risk factors, lifestyle factors and sociodemographic characteristics of the included population

All n (%)Low n (%)High n (%)P value
Total1265 (100.0)833 (100.0)432 (100.0)
Gender0.01
Female831 (65.7)569 (68.3)262 (60.6)
Male434 (34.3)264 (31.7)170 (39.4)
Age (years)<0.00
18–64725 (57.3)543 (65.2)182 (42.1)
≥65540 (42.7)290 (34.8)250 (57.9)
Diagnosis0.00
RA917 (72.5)582 (69.9)335 (77.5)
SpA, AS or PsA348 (27.5)251 (30.1)97 (22.5)
Socioeconomic factors
Cohabitant status 0.03
Alone426 (33.7)298 (35.8)128 (29.6)
With partner839 (66.3)535 (64.2)304 (70.4)
Employment <0.05
No802 (63.4)482 (57.9)320 (74.1)
Yes463 (36.6)351 (42.1)112 (25.9)
Income 0.01
Low254 (20.1)150 (18.0)104 (24.1)
Middle and high1011 (79.9)683 (82.0)328 (75.9)
Educational level 0.01
Basic449 (35.5)274 (32.9)175 (40.5)
Higher788 (62.3)541 (64.9)247 (57.2)
Unknown28 (2.2)18 (2.2)10 (2.3)
Lifestyle and CV risk factors
Alcohol intake above recommendations 0.10
No979 (77.4)648 (77.8)331 (76.6)
Yes102 (8.1)59 (7.1)43 (10.0)
Unknown184 (14.5)126 (15.1)58 (13.4)
Smoking 0.07
No978 (77.3)657 (78.9)321 (74.3)
Yes287 (22.7)176 (21.1)111 (25.7)
Exercise 0.46
Less than five times per week419 (33.1)270 (32.4)149 (34.5)
Five times or more per week846 (66.9)563 (67.6)283 (65.5)
Systolic blood pressure <0.00
<145 mmHg973 (76.9)833 (100.0)140 (32.4)
145–159 mmHg182 (14.4)182 (42.1)
≥160 mmHg110 (8.7)110 (25.5)
  • Employment, main employment during the past 12 months prior to the screening visit: yes—employed, no—retired, unemployed and others; income, personal disposable income after taxation and interest: low—lowest third, and middle and high—highest two thirds; educational level, highest attained education categorised according to the International Standard Classification of Education25: basic—0–10 years of education, higher—above 10 years of education; Alcohol intake above recommendations, alcohol intake above National Health recommendations (maximum 7 units per week for women and 14 units per week for men).

  • AS, ankylosing spondylitis; CV, cardiovascular; PsA, psoriasis arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis.